Cornell Belcher, Brilliant Corners Research's founder and president, and Brian Gardner, Stifel's chief Washington policy ...

Stifel has upgraded Alkermes (NASDAQ:ALKS) to buy from hold, citing increased confidence in the company’s narcolepsy drug ...

will present a corporate overview at the Stifel Healthcare Conference, on November 18, 2024 at 1:50 p.m. ET in New York, NY.

Stifel analyst Chris O’Cull downgraded Portillo’s (PTLO) to Hold from Buy with a $13 price target The company reported disappointing same-restaurant-sales and traffic performance, with EBITDA above ...

Stifel Nicolaus analyst Brian Brophy maintained a Buy rating on MasTec (MTZ – Research Report) yesterday and set a price target of $153.00. The company’s shares closed yesterday at $136.54. Brophy ...

B. Riley Financial Inc. agreed to sell a portion of its wealth-management business to Stifel Financial Corp. for as much as ...

Investment bank B. Riley Financial said on Friday it had agreed to sell a portion its traditional wealth management business ...

Eric Lyon, a former senior managing director, B. Riley Wealth Management, jumped to Kestra Investment Services at the start ...

After adding 27 advisors in the past three months, CEO Ronald Kruszewski looks at the "recruiting landscape" and likes what ...

Stifel Financial received final federal approval for its Stifel North Atlantic AM-Forward Fund, which is designed to provide ...

Take Raymond James Financial Inc. and Stifel Financial Corp., both of which reported quarterly earnings this week. Stifel ...

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will present at the Stifel 2024 Healthcare Conference on Tuesday, ...